(PharmaNewsWire.Com, June 09, 2017 ) Publisher estimates the global enteral stents was valued at $172.3M in 2016 and is expected to grow at a CAGR of 3.70% to reach a value of $222.1M in 2023. Increasing cancer rates, increase in diseases such as diabetes and obesity and the development of stenting technology are the key drivers for growth in this market.
Scope
- Outlook of sales volume, pricing trends, revenue trends with 2016 as base year and forecasts until 2023, for fully covered, partially covered and non - covered enteral stents. - Company share analysis in 2016, for enteral stents. - Market insights and competitive assessment of the key players within enteral stents market.
- Identify the unmet needs and understand hospitals' perceptions of the current enteral stents market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global enteral stents market in the future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
